Posts found in:

Healthcare & Life Science

KO Client Whitecap Biosciences Acquired by Bausch + Lomb Image

KO Client Whitecap Biosciences Acquired by Bausch + Lomb

KO client Whitecap Biosciences, which is developing two innovative therapies for potential use in glaucoma and geographic atrophy, was recently acquired by Bausch + Lomb, a leading global eye health company to strengthen its expanding clinical stage pipeline. “Glaucoma and geographic atrophy can cause severe vision loss, with many patients…

Keys to Successful M&A: Market Outlook & Strategic Preparedness Image

Keys to Successful M&A: Market Outlook & Strategic Preparedness

Selling a business is a huge milestone for many founders and entrepreneurs, and the timing and preparation for a transaction are critical to maximizing success in a merger or acquisition. In our recent M&A webinar with KO’s Jennifer Rosenthal and GLC Advisors’ David Bluth, we explored essential strategies for business…

KO Pharma Client Okogen Secures $3.3M Series B Funding Image

KO Pharma Client Okogen Secures $3.3M Series B Funding

KO client Okogen, a clinical stage ophthalmic pharmaceutical company specializing in innovative eyecare solutions, recently announced the successful closing of $3.3 million in financing. According to the announcement, the funding will advance the company through the completion of the Phase 2b clinical program for acute infectious conjunctivitis (AIC) and the…

KO Client ClinOne Acquired by uMotif Image

KO Client ClinOne Acquired by uMotif

KO client ClinOne, which connects, informs, and empowers participants, care partners, and sites in clinical trials with a true single platform for trial awareness, consent management, and participant experience and retention, was recently acquired by uMotif, one of the clinical research technology market’s fastest-growing companies. “We’re excited to integrate our…

KO Client Cloudbreak Pharma Enters into Licensing Agreement with Santen Image

KO Client Cloudbreak Pharma Enters into Licensing Agreement with Santen

KO client Cloudbreak Pharma, an innovative clinical-stage ophthalmology biotechnology company, recently announced that it has entered into a licensing agreement with Santen, a specialized company dedicated to eye health, to develop, manufacture, and commercialize its topical pterygium treatment. Cloudbreak founder and CEO Jinsong Ni said: “We are excited to partner…

KO Client Calorify Raises Pre-Seed Round to Commercialize Metabolism Testing Image

KO Client Calorify Raises Pre-Seed Round to Commercialize Metabolism Testing

KO client Calorify, a metabolic testing startup, recently announced that it has raised nearly $500,000 in a pre-seed round to expand its work with clinical trials, medical practices, and professional sports teams. With the funding, Calorify plans to execute its go-to-market plan for its metabolic testing kit that the company…

KO Client ABOUT Healthcare Acquires AI Company Edgility Image

KO Client ABOUT Healthcare Acquires AI Company Edgility

KO client ABOUT Healthcare, a portfolio company of Rubicon Technology Partners and a leading provider of SaaS-based hospital operations solutions for admission management and post-acute placement, recently acquired Edgility, an AI and analytics platform company that monitors and manages operations in real time, resulting in optimized capacity, enhanced patient progression,…

KO Partner Brad Schoenfeld Named Top 25 Attorney in Colorado Image

KO Partner Brad Schoenfeld Named Top 25 Attorney in Colorado

Congratulations to KO Law partner Brad Schoenfeld on being recognized as one of the “Top 25 Attorneys of Colorado” by Attorney Intel. Brad and the selected attorneys exemplify the depth of legal talent in Colorado and have specialized practices in a number of areas. Over the last 20 years at…